Searched for
SYSTEMATIX INSTITUTIONAL EQUITIES
Vedanta Aluminium shares can rally up to 28%? Why Systematix initiated coverage on the stockVedanta Aluminium shares: Systematix Institutional Equities initiated coverage on Vedanta Aluminium with a Buy rating and a target price of...- FIIs increase PSU exposure, trim stakes in private banksForeign investors reduced holdings in top private banks over the past year. They increased stakes in select public sector lenders, showing ...
- Bank of Baroda shares fall 2% after Q1 earnings. Why are brokerages slashing target prices?Bank of Baroda shares fell after a sharp 72% drop in Q1 net profit due to a one-off NMC Health settlement. Brokerages cut target prices des...
- Axis Bank shares fall 5% after Q1 earnings fail to cheer D-Street. What brokerages sayAxis Bank shares fell despite reporting a 22.5% year-on-year rise in Q1FY27 standalone net profit to Rs 7,114 crore. Net interest income (N...
- Tech Mahindra shares jump 3% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages now expectTech Mahindra shares surged after the IT major reported better-than-expected Q1 FY27 results, with net profit rising 28% YoY to Rs 1,465 cr...
- Tech Mahindra Q1 Preview: Will the IT company surprise investors with its earnings?Tech Mahindra is expected to post modest June-quarter revenue growth, led by continued strength in its telecom business, while margins are ...
- Wipro Q1 Preview: Under pressure from AI, what can investors expect from earnings?Wipro's Q1 earnings are expected to show a revenue rise, driven by acquisitions and currency. Core IT services revenue may decline sequenti...
- AI, Iran war risks weigh on Indian IT firms’ earnings outlookIndian IT companies like HCL Technologies and Wipro are reporting earnings amid AI concerns. Macroeconomic uncertainty and Middle East conf...
- Dr Reddy's shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?Dr Reddy's Laboratories shares extended their decline after the company delayed commercial supplies of its semaglutide product due to a qua...
- Suzlon Energy shares jump over 6%. Why brokerages call it India’s most investible wind energy stock?Suzlon Energy shares rose sharply on Tuesday after the company outlined an ambitious FY31 roadmap focused on expanding beyond wind energy i...
- Suzlon Energy shares jump 3%: Why brokers see up to 36% upside for ‘most investible Indian wind player’Suzlon Energy shares rose 3% after management unveiled an ambitious FY31 growth roadmap at its Investor Day. The company plans to evolve fr...
- Consumer staples sector to face growth normalization in 2nd half of 2026, updates on pricing power and channel efficiency eyedConsumer staples growth momentum is likely to moderate in the second half of FY27 as GST-related benefits phase out and high base effects s...
- RBI's foreign capital push reflects rising inflation, slowing growth concerns: ReportThe Reserve Bank of India is introducing new measures to attract foreign investment. This move aims to tackle rising inflation, slowing eco...
- Can Suzlon Energy shares rally up to 31% after Q4 results? Top brokerages weigh inBrokerages remain largely bullish on Suzlon Energy after the renewable energy major reported strong revenue growth and improving execution ...
- Indian banks remain stable despite margin pressure after RBI rate cut: ReportIndian banks are financially stable. Bad loans are under control. Profit margins face pressure from recent interest rate cuts. Banks are fo...
- Hot Stocks: Brokerage view on Patanjali, Glenmark Pharma, Voltas and Sunteck RealtyTop brokerage firms have issued buy recommendations for several companies. Systematix Equities recommended Patanjali Foods citing growth po...
- Govt lifting ban on use of sugarcane for ethanol positive for sugar companies: Pratik Tholiya“After the two weeks of confusion, this is a positive move for the sugar companies. The government allowing the industry to divert some amo...
- Britannia shares' decline continues post Q1 misses. Should you buy?Britannia's consolidated net profit rose 36% year-on-year (YoY) to Rs 458 crore for the quarter ended June 2023, missing estimates. It was ...
- Buy Mahindra CIE Automotive with a 12-month target at Rs 280Systematix Institutional Equities recommends buy rating on Mahindra CIE Automotive post March quarter results with a 12-month target price ...
- What to buy, sell and holdAngel Broking has maintained accumulate rating on Cadila Healthcare with a target price of Rs 352 citing that the company posted a robust p...
Load More
